HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Law Violations Ongoing

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

SAN FRANCISCO, March 25, 2020 — Hagens Berman urges investors in Bruker Corporation (NASDAQ: BRKR) who have suffered significant losses to submit their losses now.  The firm is investigating possible securities law violations, and certain investors may have valuable claims. 

Relevant Holding Period: Before Mar. 3, 2020 Sign Up: www.hbsslaw.com/investor-fraud/BRKR Contact An Attorney Now: [email protected] 844-916-0895

Bruker Corporation (BRKR) Investigation:

The investigation concerns whether Bruker’s accounting for income tax-related items in its financial statements conformed with GAAP.

More specifically, Bruker and senior management have repeatedly assured investors that the Company’s internal controls over financial reporting are effective.

But, on Feb. 18, 2020, after the market closed, Bruker revealed “[t]he Company’s Audit Committee of the Board of Directors has initiated an internal investigation into an allegation recently received in connection with the year-end close, primarily relating to income tax matters including the effective income tax rate for 2019 and the related income tax balance sheet accounts.”

Then, on Mar. 3, 2020, Bruker announced it would not timely file its year end 2019 financial report, blamed the internal investigation, and also revealed the assessment included the impact on financial reporting and internal controls, including disclosure controls and procedures.

These announcements have driven the price of Bruker shares sharply lower.

“We’re focused on investors’ losses and whether Bruker may have manipulated its reported GAAP and EBITDA metrics,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased shares of Bruker and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Bruker should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact: Reed Kathrein, 844-916-0895

Primary Logo